Tomiaki Yamada
JGC CORPORATION
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tomiaki Yamada.
Archive | 1992
Naoki Tahara; Norie Yoshida; Tomiaki Yamada; Makoto Umeda
Transforming growth factor-β (TGF-β)1 is a multifunctional cytokine that regulates cellular proliferation, differentiation and other functions in a wide variety of cells[1-2], Intact TGF-β has approximately MW 25,000 and is a dimer composed of two identical disulfide-linked chains of MW 12,500. In order to elucidate the functional role, structure, detection and localization in cells or tissues of TGF-β, anti-TGF-β antibodies have been needed. Though a number of anti-TGF-β polyclonal/monoclonal antibodies have been raised until now [3-6], a monoclonal antibody (Mab) which was generated against a partial synthetic peptide of TGF-β as an immunogen has never been reported.
Archive | 1992
Hirokazu Konishi; Kouji Takano; Makoto Haraguchi; Katsuaki Ohsato; Tomiaki Yamada
Pokeweed (Phytolacca americana) accumulates betacyanin as natural red pigment mainly in its fruit. It is well known that P. americana cultured cells accumulate betacyanin with their growth. We report the most effective medium to produce betacyanin and the stability of betacyanin from cultured cells.
Archive | 1992
Mikio Inoue; Tomiaki Yamada
Mammalian cell culture is being used with greater frequency every day for commercial production of pharmaceutical products. These production activities must be reproducible and provide homogeneous products in order to assure that the strict quality control necessary for process validation is achieved. Batched GMP operations in stirred tank reactors have been traditional means by which the necessary process reproducibility and product homogeneity have been achieved for validation. At the commercial scale where kilogram quantities of protein per year are required, batch suspension tank reactor production methods have been found to be the most suitable. Because commercial mammalian cell culture production may necessitate the use of anchorage-dependent cells as well as anchorage-independent ones, any system for studying this process must be capable of culture cells by both means effectively at large scale. To collect the engineering data for industrial scale pharmaceutical plant design analysis production run testing, we developed and currently operate a pilot scale mammalian cell culture system which cultivates anchorage-dependent and -independent cells at our facilities.
Archive | 2005
Cyuichi Hoshino; Tomiaki Yamada; Daisuke Taneda; Yasuhisa Nagata; Tomoaki Fujii; Takao Mase; Yoshiki Ueno
Archive | 1977
Fusao Nishida; Toshihiro Ueno; Tomiaki Yamada; Noriyuki Suzuki; Takehiko Takeda; Tsutomu Yanagihara; Katsuhiko Adachi; Tadashi Asanabe; Katsuaki Ohsato; Kintaro Tsuda; Keiichiro Watanabe
Archive | 1977
Fusao Nishida; Tomiaki Yamada; Noriyuki Suzuki; Takehiko Takeda; Tsutomu Yanagihara; Katsuhiko Adachi; Tadashi Asanabe; Katuaki Ohsato; Kintaro Tsuda
Archive | 1975
Fusao Nishida; Hiroo Matsuoka; Tomiaki Yamada; Goro Sato
Archive | 1983
Tomiaki Yamada; Masuo Kamihonoki; Hiroshi Sagara; Hiroshi Umino
Archive | 1975
Kiyoshi Morikawa; Fusao Nishida; Tomiaki Yamada; Noriyuki Suzuki; Takehiko Takeda; Tsutomu Yanagihara; Katshiko Adachi; Tadashi Asanabe; Katuaki Ohsato; Kintaro Tsuda
Archive | 2005
Cyuichi Hoshino; 星野 忠一; Tomiaki Yamada; 山田 富明; Daisuke Taneda; 種田 大介; Yasuhisa Nagata; 長田 靖久; Tomoaki Fujii; 藤井 智章; Takao Mase; 間瀬 隆男; Yoshiki Ueno; 上野 義基